• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Alteration of site-directed sugar chains of α_1-acid glycoprotein in serum of patients and its clinical significance

Research Project

Project/Area Number 13672433
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionToho University

Principal Investigator

MATSUMOTO Kojiro  Toho University, School of Pharmaceutical Sciences, Professor, 薬学部, 教授 (00095647)

Project Period (FY) 2001 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 2003: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2002: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 2001: ¥900,000 (Direct Cost: ¥900,000)
Keywordsα_1-acid glycoprotein / N-glycans / α1-3 fucosylation / sialyl Lewis X antigen / MALDI-TOFMS / inflammation / α_1-酸性糖蛋白 / 糖鎖 / サイトカイン / α1-酸性糖蛋白 / 糖鎖結合部位特異的糖鎖構造 / 糖尿病
Research Abstract

N-Glycans of α_1-acid glycoprotein (AGP) in sera of healthy individuals and patients with inflammation were comparatively studied (Clin Chim Acta, 2003). N-Glycans released from purified AGP with N-glycanase were treated with sialidase and subjected to MALDI-TOFMS analysis. N-Glycans of both groups were composed with bi-, tri-and tetra-antennary complex-types and the contents of α1-3 fucosylated N-glycans were bi-□tri-<tetra-antennary. In inflammation patients, increases in bi-antennary, decreases in tri-and tetra-antennary and increases in α1-3 fucosylation were significant.
N-Glycans of 5 glycosylation sites in AGP were separately compared (in preparation). Purified AGP was treated with endopeptidase Glu-C and N-glycans of each glycopeptides isolated by a reversed phase HPLC were determined by MALDI-TOFMS. Each glycosylation site was composed with different and characteristic antennary glycans, bi-and tri-in sites 1 and 2 and tri-and tetra-antennary in sites 3 to 5. In inflammatory, i … More ncreases in bi-antennary, decreases in tri-and tetra-antennary and increases in α_1-3 fucosylation were commonly observed in all glycosylation sites, in larger degrees in acute than chronic inflammation.
To determine cancerous alteration of N-glycans, N-glycans of glycoproteins secreted from human hepatoma cell lines HuH7 and HepG2 were studied (Anal Sci, 2003). Increases in tri-and tetra-antennary and α1-3 fucosylation were prominently detected in several glycoproteins secreted by HepG2 cells. Moreover, α1-3 fucosylation activities toward NeuAcα2-3Galβ1-4GlcNAc-R were detected 20-fold highly in HepG2, comparing to HuH7.
To clarify the biological roles of high-fucosylated N-glycans, NK cells were stimulated on plates coated with high-fucosylated glycoproteins purified from HepG2 culture, medium (unpublished result). High-fucosylated glycoproteins will modulate the NK cell functions, since protein with 17kDa was stimulated to phosphorylate on its tyrosine residues. Further study is in progress. Less

Report

(4 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • 2001 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Y Azuma, M Murata, K Matsumoto: "Alteration of sugar chains on α_1-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro"Clin Chim Acta. 294(1-2). 93-103 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] K Higai, Y Azuma, Y Aoki, K Matsumoto: "Altered glycosylation of α_1-acid glycoprotein in patients with inflammation and diabetes mellitus"Clin Chim Acta. 329(1-2). 117-125 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] K Higai, K Shibukawa, S Muto, K Matsumoto: "Targeted proteo-glycomics analysis of sialyl Lewis X antigen expressing glycoproteins secreted by human hepatoma cell line"Anal Sci. 19(1). 85-92 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y Azuma, M Sakanashi, K Matsumoto: "The effect of α2,6-linked sialic acid on anti-IgM antibody-induced apoptosis in Karaos cells"Glycoconj J. 18(5). 419-424 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y Azuma, Y Inami, K Matsumoto: "Alterations in cell surface phosphatidylserine and sugar chains during apoptosis and their time dependent role in phagocytosis by macrophage"Biol Pharm Bull. 25(10). 1277-1281 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] A Tanieuchi, K Saito, T Kubota, K Matsumoto: "Characterization of the promoter region of the human Galβ1,3(4)GlcNAc α2,3-sialyltransferase III(hST3Gal III) gene"Biochim Biophys Acta. 1626(1-3). 92-96 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y Azuma, M Murata, K Matsumoto: "Alteration of sugar chains on α1-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro"Clin Chim Acta. 294(1-2). 93-103 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] K Higai, Y Azuma, Y Aoki, K Matsumoto: "Altered glycosylation of α1-acid glycoprotein in patients with inflammation and diabetes mellitus"Clin Chim Acta. 329(1-2). 117-125 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] K Higai, K Shibukawa, S Muto, K Matsumoto: "Targeted proteo-glycomics analysis of sialyl Lewis X antigen expressing glycoproteins secreted by human hepatoma cell line"Anal Sci. 19(1). 85-92 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] A Taniguchi, I Yoshikawa, K Matsumoto: "Genomic structure and transcriptional regulation of human Galβ1,4(3) GalNAc α2,3-sialyltrans-ferase (hST3Gal I) gene."Glycobiology. 11(3). 241-247 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] S Muto, T Takada, K Matsumoto: "Biological activities of human mannose-binding lecthin bound to two different ligand sugar structures, Lewis A and Lewis B antigens and high-mannose oligosaccharides."Biochim Biophys Acta. 1527(1-2). 39-46 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] A Taniguchi, R Kaneta, K Morishita, K Matsumoto: "Gene structure and transcriptional regulation of human Galβ1,4(3) GlcNAc α2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line."Biochem Biophys Res Commun. 287(5). 1148-1156 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y Azuma, M Sakanashi, K Matsumoto: "The effect of α2,6-linked sialic acid on anti-IgM antibody-induced apoptosis in Ramos cells."Glycoconj J. 18(5). 419-424 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y Azuma, Y Inami, K Matsumoto: "Alterations in cell surface phosphatidylserine and sugar chains during apoptosis and their time dependent role in phagocytosis by macrophase."Biol Pharm Bull. 25(10). 1277-1281 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] A Taniguchi, T Morishuina, Y Tsujita, Y Matsumoto, K Matsumoto: "Genomic structure, expression and transcriptional regulation of human Galβ1,3GalNAc α2,3-sialyltransferase gene."Biochem Biophys Res Commun. 300(2). 570-576 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] A Taniguchi, M Hioki, K Matsumoto: "Transcriptional regulation of human Galβ1,3GalNAc/Galβ1,4GlcNAc α2,3-sialyltransferase (hST3 GalVI) gene in testis and ovary cell lines."Biochem Biophys Res Commun. 301(3). 764-768 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] A Taniguchi, K Saito, T Kubota, K Matsumoto: "Characterization of the promoter region of the human Galβ1,3(4)GlcNAc α2,3-sialyltrans-ferase III(hST3Gal III) gene."Biochem Biophys Acta. 1626(1-3). 92-96 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] L Xu, Y Kurusu, K Takizawa, J Tanaka, K Matsumoto, A Taniguchi: "Transcriptional regulation of human β-galactoside α2,6-sialyltrans-ferase (hST6Gal I) gene in colon adenocarcinoma cell line."Biochem Biophys Res Commun. 307(4). 1070-1074 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] K.Higai, K.SHibukawa, S.Muto, K.Matsumoto: "Targeted Proteo-glycomics analysis of sialyl Lewis X antigen expressing glycoproteins Secreted by human hepatoma cell line"Anal. Sci.. 19. 85-92 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] K.Higai, Y.Azuma, Y.Aoki, K.Matsumoto: "Altered glycosylation of α_1-acid glycoprotein in patients with inflammation and diabetes mellitus"Clin. Chim.. Acta. 329. 117-125 (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi